December 17, 2025

Ankar Raises $20M Series A for AI Patent Filing

Kajetan A. Uhlig

Ankar

Palantir alumni founded Ankar, which raised $20M Series A led by Atomico to streamline patent filings using AI technology.

Ankar Brings AI to Patent Filing

Ankar, founded by Palantir alumni, has raised $20 million in a Series A led by Atomico to streamline patent filings with AI technology. The company targets one of the most inefficient processes in the innovation economy: the preparation and filing of patents.

The Patent Filing Bottleneck

Patent filing is a multi-billion dollar market dominated by manual, time-intensive processes. Patent attorneys spend hundreds of hours per application researching prior art, drafting claims, and navigating complex filing requirements across multiple jurisdictions. Ankar's AI platform automates the most labor-intensive components of this workflow, dramatically reducing the time and cost required to file high-quality patents while maintaining the legal precision that the process demands.

Palantir DNA and Atomico Backing

The founding team's Palantir background brings expertise in building enterprise software that handles complex, structured data at scale, exactly the capability required to process the intricate legal and technical requirements of patent filings. Atomico's lead position at $20M signals conviction from one of Europe's most respected technology investors that Ankar has both the team and the technology to transform how intellectual property is created and protected globally.

Playing field

AI / Machine Learning

The most transformative technology cycle since the internet, reshaping every industry with foundation models and autonomous systems.

AI / Machine Learning

SaaS

The bedrock of enterprise software value creation, now being reshaped by AI, vertical specialization, and product-led growth.

Continue reading

Hypersonica

Hypersonica Raises EUR23M and Achieves Mach 6 Test

February 10, 2026

Fundamental Technologies

Fundamental Technologies Raises $225M Series A at $1.4B

February 5, 2026

ElevenLabs

ElevenLabs Raises $500M Series D at $11B Valuation

February 4, 2026

UiPath Acquires WorkFusion: A Portfolio Milestone

February 1, 2026

By choosing to build a company, you acknowledge and accept the potential risks associated with this decision. These may include, but are not limited to: an unhealthy obsession with fundraising, the constant sensation of being simultaneously ahead and hopelessly behind, and the inability to have a normal conversation without referencing burn multiples, CAC ratios, or other KPIs. Founders may experience chronic sleep deprivation, imposter syndrome, and an inexplicable desire to read term sheets at inappropriate moments. Side effects may also include assembling a team of brilliant misfits, firing some of them, rehiring others, and wondering if you should have just opened a coffee shop instead. In rare cases, sustained effort and market timing may result in a successful exit, though this often leads to immediate relapse into founding another startup. By continuing this journey, you waive all rights to predictable weekends, stable income, and work-life balance. But hey, no one forced you. If symptoms persist, congratulations, you’re a real founder.